[CODES]
"Diagnosis Code(ICD-10)"
Diagnosis Code(ICD-10),Diagnosis_Code_ICD10,CMS_ACCEPTED,3,1033
A00.0,Cholera due to Vibrio cholerae 01, biovar cholerae,N,
A79.82,Anaplasmosis A. phagocytophilum,N,
C56.3,Malignant neoplasm of bilateral ovaries,N,
C79.63,Secondary malignant neoplasm of bilateral ovaries,N,
C84.7A,Anaplastic large cell lymphoma, ALK-negative, breast,N,
D55.2,Anemia due to disorders of glycolytic enzymes,N,
D55.21,Anemia due to pyruvate kinase deficiency,N,
D55.29,Anemia due to other disorders of glycolytic enzymes,N,
D75.83,Thrombocytosis,N,
D75.838,Other thrombocytosis,N,
D75.839,Thrombocytosis, unspecified,N,
D89.44,Hereditary alpha tryptasemia,N,
E75.244,Niemann-Pick disease type A/B,N,
F32.A,Depression, unspecified,N,
F78,Other intellectual disabilities,N,
F78.A,Other genetic related intellectual disabilities,N,
F78.A1,SYNGAP1-related intellectual disability,N,
F78.A9,Other genetic related intellectual disability,N,
G04.82,Acute flaccid myelitis,N,
G44.86,Cervicogenic headache,N,
G92,Toxic encephalopathy,N,
G92.0,Immune effector cell-associated neurotoxicity syndrome,N,
G92.00,Immune effector cell-associated neurotoxicity syndrome, grade unspecified,N,
G92.01,Immune effector cell-associated neurotoxicity syndrome, grade 1,N,
G92.02,Immune effector cell-associated neurotoxicity syndrome, grade 2,N,
G92.03,Immune effector cell-associated neurotoxicity syndrome, grade 3,N,
G92.04,Immune effector cell-associated neurotoxicity syndrome, grade 4,N,
G92.05,Immune effector cell-associated neurotoxicity syndrome, grade 5,N,
G92.8,Other toxic encephalopathy,N,
G92.9,Unspecified toxic encephalopathy,N,
I5A,Non-ischemic myocardial injury non-traumatic,N,
K22.8,Other specified diseases of esophagus,N,
K22.81,Esophageal polyp,N,
K22.82,Esophagogastric junction polyp,N,
K22.89,Other specified disease of esophagus,N,
K31.A,Gastric intestinal metaplasia,N,
K31.A0,Gastric intestinal metaplasia, unspecified,N,
K31.A1,Gastric intestinal metaplasia without dysplasia,N,
K31.A11,Gastric intestinal metaplasia without dysplasia, involving the antrum,N,
K31.A12,Gastric intestinal metaplasia without dysplasia, involving the body corpus,N,
K31.A13,Gastric intestinal metaplasia without dysplasia, involving the fundus,N,
K31.A14,Gastric intestinal metaplasia without dysplasia, involving the cardia,N,
K31.A15,Gastric intestinal metaplasia without dysplasia, involving multiple sites,N,
K31.A19,Gastric intestinal metaplasia without dysplasia, unspecified site,N,
K31.A2,Gastric intestinal metaplasia with dysplasia,N,
K31.A21,Gastric intestinal metaplasia with low grade dysplasia,N,
K31.A22,Gastric intestinal metaplasia with high grade dysplasia,N,
K31.A29,Gastric intestinal metaplasia with dysplasia, unspecified,N,
L24.A,Irritant contact dermatitis due to friction or contact with body fluids,N,
L24.A0,Irritant contact dermatitis due to friction or contact with body fluids, unspecified,N,
L24.A1,Irritant contact dermatitis due to saliva,N,
L24.A2,Irritant contact dermatitis due to fecal, urinary or dual incontinence,N,
L24.A9,Irritant contact dermatitis due friction or contact with other specified body fluids,N,
L24.B,Irritant contact dermatitis related to stoma or fistula,N,
L24.B0,Irritant contact dermatitis related to unspecified stoma or fistula,N,
L24.B1,Irritant contact dermatitis related to digestive stoma or fistula,N,
L24.B2,Irritant contact dermatitis related to respiratory stoma or fistula,N,
L24.B3,Irritant contact dermatitis related to fecal or urinary stoma or fistula,N,
M31.1,Thrombotic microangiopathy,N,
M31.10,Thrombotic microangiopathy, unspecified,N,
M31.11,Hematopoietic stem cell transplantation-associated thrombotic microangiopathy HSCT-TMA,N,
M31.19,Other thrombotic microangiopathy,N,
M35.05,Sjögren syndrome with inflammatory arthritis,N,
M35.06,Sjögren syndrome with peripheral nervous system involvement,N,
M35.07,Sjögren syndrome with central nervous system involvement,N,
M35.08,Sjögren syndrome with gastrointestinal involvement,N,
M35.0A,Sjögren syndrome with glomerular disease,N,
M35.0B,Sjögren syndrome with vasculitis,N,
M35.0C,Sjögren syndrome with dental involvement,N,
M45.A,Non-radiographic axial spondyloarthritis,N,
M45.A0,Non-radiographic axial spondyloarthritis of unspecified sites in spine,N,
M45.A1,Non-radiographic axial spondyloarthritis of occipito-atlanto-axial region,N,
M45.A2,Non-radiographic axial spondyloarthritis of cervical region,N,
M45.A3,Non-radiographic axial spondyloarthritis of cervicothoracic region,N,
M45.A4,Non-radiographic axial spondyloarthritis of thoracic region,N,
M45.A5,Non-radiographic axial spondyloarthritis of thoracolumbar region,N,
M45.A6,Non-radiographic axial spondyloarthritis of lumbar region,N,
M45.A7,Non-radiographic axial spondyloarthritis of lumbosacral region,N,
M45.A8,Non-radiographic axial spondyloarthritis of sacral and sacrococcygeal region,N,
M45.AB,Non-radiographic axial spondyloarthritis of multiple sites in spine,N,
M54.5,Low back pain,N,
M54.50,Low back pain, unspecified,N,
M54.51,Vertebrogenic low back pain,N,
M54.59,Other low back pain,N,
P00.82,Newborn affected by positive maternal group B streptococcus GBS colonization,N,
P09,Abnormal findings on neonatal screening,N,
P09.1,Abnormal findings on neonatal screening for inborn errors of metabolism,N,
P09.2,Abnormal findings on neonatal screening for congenital endocrine disease,N,
P09.3,Abnormal findings on neonatal screening for congenital hematologic disorders,N,
P09.4,Abnormal findings on neonatal screening for cystic fibrosis,N,
P09.5,Abnormal findings on neonatal screening for critical congenital heart disease,N,
P09.6,Abnormal findings on neonatal screening for neonatal hearing loss,N,
P09.8,Other abnormal findings on neonatal screening,N,
P09.9,Abnormal findings on neonatal screening, unspecified,N,
R05,Cough,N,
R05.1,Acute cough,N,
R05.2,Subacute cough,N,
R05.3,Chronic cough,N,
R05.4,Cough syncope,N,
R05.8,Other specified cough,N,
R05.9,Cough, unspecified,N,
R35.8,Other polyuria,N,
R35.81,Nocturnal polyuria,N,
R35.89,Other polyuria,N,
R45.88,Nonsuicidal self-harm,N,
R63.3,Feeding difficulties,N,
R63.30,Feeding difficulties, unspecified,N,
R63.31,Pediatric feeding disorder, acute,N,
R63.32,Pediatric feeding disorder, chronic,N,
R63.39,Other feeding difficulties,N,
R79.83,Abnormal findings of blood amino-acid level,N,
S06.A,Traumatic brain compression and herniation,N,
S06.A0,Traumatic brain compression without herniation,N,
S06.A0XA,Traumatic brain compression without herniation, initial encounter,N,
S06.A0XD,Traumatic brain compression without herniation, subsequent encounter,N,
S06.A0XS,Traumatic brain compression without herniation, sequela,N,
S06.A1,Traumatic brain compression with herniation,N,
S06.A1XA,Traumatic brain compression with herniation, initial encounter,N,
S06.A1XD,Traumatic brain compression with herniation, subsequent encounter,N,
S06.A1XS,Traumatic brain compression with herniation, sequela,N,
T40.71,Poisoning by, adverse effect of and underdosing of cannabis derivatives,N,
T40.711,Poisoning by cannabis, accidental unintentional,N,
T40.711A,Poisoning by cannabis, accidental unintentional, initial encounter,N,
T40.711D,Poisoning by cannabis, accidental unintentional, subsequent encounter,N,
T40.711S,Poisoning by cannabis, accidental unintentional, sequela,N,
T40.712,Poisoning by cannabis, intentional self-harm,N,
T40.712A,Poisoning by cannabis, intentional self-harm, initial encounter,N,
T40.712D,Poisoning by cannabis, intentional self-harm, subsequent encounter,N,
T40.712S,Poisoning by cannabis, intentional self-harm, sequela,N,
T40.713,Poisoning by cannabis, assault,N,
T40.713A,Poisoning by cannabis, assault, initial encounter,N,
T40.713D,Poisoning by cannabis, assault, subsequent encounter,N,
T40.713S,Poisoning by cannabis, assault, sequela,N,
T40.714,Poisoning by cannabis, undetermined,N,
T40.714A,Poisoning by cannabis, undetermined, initial encounter,N,
T40.714D,Poisoning by cannabis, undetermined, subsequent encounter,N,
T40.714S,Poisoning by cannabis, undetermined, sequela,N,
T40.715,Adverse effect of cannabis,N,
T40.715A,Adverse effect of cannabis, initial encounter,N,
T40.715D,Adverse effect of cannabis, subsequent encounter,N,
T40.715S,Adverse effect of cannabis, sequela,N,
T40.716,Underdosing of cannabis,N,
T40.716A,Underdosing of cannabis, initial encounter,N,
T40.716D,Underdosing of cannabis, subsequent encounter,N,
T40.716S,Underdosing of cannabis, sequela,N,
T40.72,Poisoning by, adverse effect of and underdosing of synthetic cannabinoids,N,
T40.721,Poisoning by synthetic cannabinoids, accidental unintentional,N,
T40.721A,Poisoning by synthetic cannabinoids, accidental unintentional, initial encounter,N,
T40.721D,Poisoning by synthetic cannabinoids, accidental unintentional, subsequent encounter,N,
T40.721S,Poisoning by synthetic cannabinoids, accidental unintentional, sequela,N,
T40.722,Poisoning by synthetic cannabinoids, intentional self-harm,N,
T40.722A,Poisoning by synthetic cannabinoids, intentional self-harm, initial encounter,N,
T40.722D,Poisoning by synthetic cannabinoids, intentional self-harm, subsequent encounter,N,
T40.722S,Poisoning by synthetic cannabinoids, intentional self-harm, sequela,N,
T40.723,Poisoning by synthetic cannabinoids, assault,N,
T40.723A,Poisoning by synthetic cannabinoids, assault, initial encounter,N,
T40.723D,Poisoning by synthetic cannabinoids, assault, subsequent encounter,N,
T40.723S,Poisoning by synthetic cannabinoids, assault, sequela,N,
T40.724,Poisoning by synthetic cannabinoids, undetermined,N,
T40.724A,Poisoning by synthetic cannabinoids, undetermined, initial encounter,N,
T40.724D,Poisoning by synthetic cannabinoids, undetermined, subsequent encounter,N,
T40.724S,Poisoning by synthetic cannabinoids, undetermined, sequela,N,
T40.725,Adverse effect of synthetic cannabinoids,N,
T40.725A,Adverse effect of synthetic cannabinoids, initial encounter,N,
T40.725D,Adverse effect of synthetic cannabinoids, subsequent encounter,N,
T40.725S,Adverse effect of synthetic cannabinoids, sequela,N,
T40.726,Underdosing of synthetic cannabinoids,N,
T40.726A,Underdosing of synthetic cannabinoids, initial encounter,N,
T40.726D,Underdosing of synthetic cannabinoids, subsequent encounter,N,
T40.726S,Underdosing of synthetic cannabinoids, sequela,N,
T80.82,Complication of immune effector cellular therapy,N,
T80.82XA,Complication of immune effector cellular therapy, initial encounter,N,
T80.82XD,Complication of immune effector cellular therapy, subsequent encounter,N,
T80.82XS,Complication of immune effector cellular therapy, sequela,N,
U09,Post COVID-19 condition,N,
U09.9,Post COVID-19 condition, unspecified,N,
Y35.899,Legal intervention involving other specified means, unspecified person injured,N,
Y35.899A,Legal intervention involving other specified means, unspecified person injured, initial encounter,N,
Y35.899D,Legal intervention involving other specified means, unspecified person injured, subsequent encounter,N,
Y35.899S,Legal intervention involving other specified means, unspecified person injured, sequela,N,
Z55.5,Less than a high school diploma,N,
Z58,Problems related to physical environment,N,
Z58.6,Inadequate drinking-water supply,N,
Z59.0,Homelessness,N,
Z59.00,Homelessness unspecified,N,
Z59.01,Sheltered homelessness,N,
Z59.02,Unsheltered homelessness,N,
Z59.4,Lack of adequate food,N,
Z59.41,Food insecurity,N,
Z59.48,Other specified lack of adequate food,N,
Z59.8,Other problems related to housing and economic circumstances,N,
Z59.81,Housing instability, housed,N,
Z59.811,Housing instability, housed, with risk of homelessness,N,
Z59.812,Housing instability, housed, homelessness in past 12 months,N,
Z59.819,Housing instability, housed unspecified,N,
Z59.89,Other problems related to housing and economic circumstances,N,
Z71.85,Encounter for immunization safety counseling,N,
Z91.014,Allergy to mammalian meats,N,
Z91.5,Personal history of self-harm,N,
Z91.51,Personal history of suicidal behavior,N,
Z91.52,Personal history of nonsuicidal self-harm,N,
Z92.85,Personal history of cellular therapy,N,
Z92.850,Personal history of Chimeric Antigen Receptor T-cell therapy,N,
Z92.858,Personal history of other cellular therapy,N,
Z92.859,Personal history of cellular therapy, unspecified,N,
Z92.86,Personal history of gene therapy,N,